Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel… read more

Exelixis and Adagene Enter into Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies Exelixis, Inc. (Nasdaq: EXEL) and Adagene today announced a collaboration and license agreement under which Exelixis will utilize Adagene’s SAFEbody™… read more

Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located… read more

Moderna Therapeutics Expands Pipeline of Innovative mRNA-based Vaccines to Target HIV, Nipah Virus and More Moderna recently announced that it’ll continue to pursue advancement programs around three new vaccine candidates in 2021. These… read more

A Step Closer to Developing 'Smart' Stem Cells Made From Human Fat The scientists at University of New South Wales created iMS cells in a lab by exposing human fat cells to a… read more

Bone Therapeutics and Rigenerand to partner for the development of Cell Therapy products Bone Therapeutics and Rigenerand recently announced that both companies would be partnering to develop and manufacture medicinal products for cell… read more

Sinovac's COVID-19 vaccine shows efficacy less than 60% in its last stage clinical trial held in Brazil.  Sinovac’s COVID-19 vaccine showed a general efficacy of less than 60% in its late-stage trial in… read more

Cytiva has completed the Modular Biologics factory for Lonza. Cytiva has recently completed another KUBio installation to Lonza, in Guangzhou Biopark, China.  This is Lonza's first manufacturing site for biologics in China. Lonza… read more

Bayer leads a $105 million in funding to develop a cell therapy pipeline.  Bayer's venture investment arm is leading a $105 million funding round in closely held Senti Biosciences which uses synthetic biology… read more

CureVac partners with Bayer for COVID-19 vaccine deal. CureVac has recently agreed to an alliance with Bayer to get global support in seeking approval for its experimental COVID-19 vaccine and support for vaccine… read more